XML 49 R39.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Commitments and Contingencies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract] |
Summary of Outstanding Non-cancelable Purchase Obligations | As of December 31, 2023, the Company had the following outstanding non-cancelable purchase obligations (in thousands):
|  | Purchase Obligations Due In The Year Ending December 31, |
|  | 2024 |  |  | 2025 |  |  | Total |
Manufacture and supply of pamrevlumab |  | $ | 17,995 |  |  | $ | 4,827 |  |  | $ | 22,822 |
Manufacture and supply of roxadustat |  |  | 573 |  |  |  | 1,146 |  |  |  | 1,719 |
Other purchases and programs |  |  | 11,750 |  |  |  | — |  |  |  | 11,750 |
Total |  | $ | 30,318 |  |  | $ | 5,973 |  |  | $ | 36,291 |

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of unconditional purchase obligation recognized as liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-6 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1 + Details
Name: | us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration